4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000673
Chief Executive Officer sold 11,520 shares at $19.05 ($219,456)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-02 | Sale : show line 1 in the form 10b5-1 | −11,520 | $19.05 | $219,456 | 3,764,252 | D |
| Open-market sales · 11,520 sh · avg $19.05 · $219,456 | ||||||
Loading xslF345X05/wk-form4_1736204845.xml…